Literature DB >> 23272952

Risk factors survey for extracorporeal shockwave lithotripsy-induced renal hematoma.

Hsiang-ying Lee1, Yi-Hsin Yang, Jung-Tsung Shen, Mei-Yu Jang, Paul Ming-Chen Shih, Wen-Jeng Wu, Chun-Hsiung Huang, Yii-her Chou, Yung-Shun Juan.   

Abstract

BACKGROUND AND
PURPOSE: Shockwave lithotripsy (SWL) is a widely used treatment for patients with renal and ureteral stones because of its noninvasive approach. Although minor complications occur in most patients, a relative severe complication, perirenal or subcapsular hematoma, may also occur. We evaluate the possible risk factors for perirenal hematoma after SWL. PATIENTS AND METHODS: Between 2001 and 2011, a total of 10,887 SWL treatments were performed for urolithiasis. All SWL procedures were performed using a Siemens Lithostar multiline lithotripter at a frequency of 2/sec under intermittent fluoroscopic guidance. All these patients underwent outpatient treatment without general anesthesia, but pethidine was administered for pain control. Treatment episodes were retrospectively reviewed for medical history, patient age, sex, body mass index (BMI), mean arterial pressure at induction, location of stone, total number of shockwaves, and peak shockwave intensity. We also compared the hematoma group with the control group (no hematoma formation after SWL with matched age and sex) for various factors.
RESULTS: After 10,887 treatment episodes on a total of 6177 patients during this period, subcapsular or perirenal hematoma developed in 20 patients for a total incident rate of 0.32%. Eighteen patients had the symptom of flank pain, and 2 patients received a diagnosis accidentally without symptoms. Four patients received a blood transfusion because of low hemoglobulin concentration. All of them received conservative and supportive treatment without surgical exploration. Ten (50%) patients had a history of hypertension. Renal hematoma developed in 11 patients at the second or third SWL treatment. Hypertension, higher BMI, and larger stone size are predisposing risk factors (P=0.022, 0.026 and 0.026, respectively) for renal hematoma.
CONCLUSIONS: Renal hematoma is a rare (incidence rate, 0.32%) but possibly lethal complication. The most common symptoms of renal hematoma are severe flank pain and hematuria. A history of hypertension and higher BMI are important predisposing factors to perirenal hematoma.

Entities:  

Mesh:

Year:  2013        PMID: 23272952     DOI: 10.1089/end.2012.0619

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  14 in total

Review 1.  Arguments for choosing extracorporeal shockwave lithotripsy for removal of urinary tract stones.

Authors:  Hans-Göran Tiselius; Christian G Chaussy
Journal:  Urolithiasis       Date:  2015-08-28       Impact factor: 3.436

2.  Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments.

Authors:  M J Schnabel; M Gierth; C G Chaussy; K Dötzer; M Burger; H M Fritsche
Journal:  Urolithiasis       Date:  2014-01-14       Impact factor: 3.436

Review 3.  How to maximize the efficacy of shockwave lithotripsy.

Authors:  Neophytos Petrides; Safiyah Ismail; Faqar Anjum; Seshadri Sriprasad
Journal:  Turk J Urol       Date:  2020-10-30

4.  Hospital admission for treatment of complications after extracorporeal shock wave lithotripsy for renal stones: a study of risk factors.

Authors:  Ahmed R El-Nahas; Diaa-Eldin Taha; Mohamed M Elsaadany; Mohamed H Zahran; Mohamed Hassan; Khaled Z Sheir
Journal:  Urolithiasis       Date:  2017-05-29       Impact factor: 3.436

Review 5.  Shockwave lithotripsy: techniques for improving outcomes.

Authors:  Tadeusz Kroczak; Kymora B Scotland; Ben Chew; Kenneth T Pace
Journal:  World J Urol       Date:  2017-06-12       Impact factor: 4.226

6.  Tissue neutrophil elastase contributes to extracorporeal shock wave lithotripsy-induced kidney damage and the neutrophil elastase inhibitor, sivelestat, attenuates kidney damage with gratifying immunohistopathological and biochemical findings: an experimental study.

Authors:  Aykut Colakerol; Serhat Suzan; Mustafa Zafer Temiz; Serkan Gonultas; Serdar Aykan; Sule Ozsoy; Suat Hayri Kucuk; Emrah Yuruk; Engin Kandırali; Atilla Semercioz
Journal:  Urolithiasis       Date:  2021-11-15       Impact factor: 3.436

7.  A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.

Authors:  Fabio Nussberger; Beat Roth; Tobias Metzger; Bernhard Kiss; George N Thalmann; Roland Seiler
Journal:  Urolithiasis       Date:  2016-08-30       Impact factor: 3.436

8.  Autophagy activation protects shock wave induced renal tubular epithelial cell apoptosis may through modulation of Akt/ GSK-3β pathway.

Authors:  Qingzhi Long; Xiang Li; Hui He; Dalin He
Journal:  Int J Biol Sci       Date:  2016-11-24       Impact factor: 6.580

9.  Successful evacuation of large perirenal hematoma after extracorporeal shock wave lithotripsy (ESWL) - step 1 of the IDEAL recommendations of surgical innovation.

Authors:  Steffen Hallmann; Jan Petersein; Jürgen Ruttloff; Thorsten H Ecke
Journal:  Clin Case Rep       Date:  2017-01-16

10.  Safety and feasibility of day case ureteroscopy and laser lithotripsy (URSL) in patients with a solitary kidney.

Authors:  Anngona Ghosh; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2016-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.